[27- Hydroxycholesterol reverses estradiol induced inhibition of platelet aggregation in postmenopausal women]. / Efecto del 27- hidroxicolesterol en la acción antiplaquetaria de estradiol en mujeres postmenopáusicas.
Rev Med Chil
; 144(11): 1377-1381, 2016 Nov.
Article
em Es
| MEDLINE
| ID: mdl-28394953
BACKGROUND: The decline of estrogen levels increases cardiovascular risk in women. Platelets express estrogen receptors and 17ß-estradiol- (E2) can produce a protective effect on thrombus formation. The hydroxylation of cholesterol generates several sterols and 27-hydroxycholesterol (27HC) predominates in circulation. AIM: To evaluate the effect of 27HC as an endogenous antagonist of the anti-aggregating properties of E2 in platelets of postmenopausal women. MATERIAL AND METHODS: Platelet function of postmenopausal women was evaluated ex-vivo. Platelets pre-incubated with 27HC in the presence or absence of E2, were stimulated with collagen. Aggregation was evaluated using turbidimetry using a Chrono-log aggregometer. RESULTS: Collagen-stimulated platelet aggregation was significantly inhibited by E2. The inhibitory effect of E2 on collagen-stimulated platelet aggregation was significantly reversed in the presence of 27HC. CONCLUSIONS: The suppressive effect of E2 on platelet aggregation is inhibited by 27HC, which could contribute to increase cardiovascular risk in postmenopausal women.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Agregação Plaquetária
/
Pós-Menopausa
/
Antagonistas de Estrogênios
/
Estrogênios
/
Hidroxicolesteróis
Tipo de estudo:
Etiology_studies
/
Risk_factors_studies
Limite:
Aged
/
Female
/
Humans
/
Middle aged
Idioma:
Es
Revista:
Rev Med Chil
Ano de publicação:
2016
Tipo de documento:
Article